20 "Past Their Prime" Stocks to Dump From Your Portfolio - 20 of 20 Slide 20Back to 19Next Slideshow Back to 19Next Slideshow Celldex Therapeutics (NASDAQ:CLDX)Celldex Therapeutics, Inc, a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. Read More Trailing Twelve Months EPS: ($2.85)2024 EPS Estimate: ($2.50)2025 EPS Estimate: ($3.03)Current Stock Price $40.77Consensus Rating Moderate BuyRatings Breakdown 6 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.Consensus Price Target $63.83 (56.6% Upside)More Investing Slideshows:7 Undervalued Growth Stocks Ready for Reversal7 ETFs to Invest in Now for Maximum Returns7 Low Beta Stocks for the Risk-Averse Investor7 Best REITs to Buy as the Interest Rates Fall7 Best Stocks Under $5 to Buy Now7 Consumer Discretionary Stocks That Will Heat Up with Rate Cuts 7 of the Best Options for Investing $5,000 in 20257 Energy Stocks with Attractive High-Yield Dividends7 Stocks That Can Help You Cash In on the GLP-1 Revolution7 Industrial Stocks with Safe, Growing DividendsSlide 20Back to 19Next Slideshow Biden’s Capital Gains Tax to Devastate Savings! (Ad)Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide <<More From MarketBeatBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | Sponsored7 Consumer Discretionary Stocks That Will Heat Up with Rate Cuts As the second quarter earnings season ends, a recurring theme for many companies that rely on the discretionar...MarketBeatBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored20 "Past Their Prime" Stocks to Dump From Your PortfolioDid you know the S&P 500 as we know it today does not look anything close to what it looked like 30 years ...MarketBeatHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | Sponsored7 Chip Stocks Leading the AI RevolutionArtificial intelligence (AI) has been around for longer than many investors may think. However, the launch of ...MarketBeat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Slide 20Back to 19Next Slideshow Back to 19Next Slideshow Celldex Therapeutics (NASDAQ:CLDX)Celldex Therapeutics, Inc, a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. Read More Trailing Twelve Months EPS: ($2.85)2024 EPS Estimate: ($2.50)2025 EPS Estimate: ($3.03)Current Stock Price $40.77Consensus Rating Moderate BuyRatings Breakdown 6 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.Consensus Price Target $63.83 (56.6% Upside)More Investing Slideshows:7 Undervalued Growth Stocks Ready for Reversal7 ETFs to Invest in Now for Maximum Returns7 Low Beta Stocks for the Risk-Averse Investor7 Best REITs to Buy as the Interest Rates Fall7 Best Stocks Under $5 to Buy Now7 Consumer Discretionary Stocks That Will Heat Up with Rate Cuts 7 of the Best Options for Investing $5,000 in 20257 Energy Stocks with Attractive High-Yield Dividends7 Stocks That Can Help You Cash In on the GLP-1 Revolution7 Industrial Stocks with Safe, Growing DividendsSlide 20Back to 19Next Slideshow Biden’s Capital Gains Tax to Devastate Savings! (Ad)Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide <<More From MarketBeatBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | Sponsored7 Consumer Discretionary Stocks That Will Heat Up with Rate Cuts As the second quarter earnings season ends, a recurring theme for many companies that rely on the discretionar...MarketBeatBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored20 "Past Their Prime" Stocks to Dump From Your PortfolioDid you know the S&P 500 as we know it today does not look anything close to what it looked like 30 years ...MarketBeatHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | Sponsored7 Chip Stocks Leading the AI RevolutionArtificial intelligence (AI) has been around for longer than many investors may think. However, the launch of ...MarketBeat
